Source: Health Canada shortage reports · Updated Jul 10, 2026
Some Voriconazole products are in shortage in Canada (2 of 12 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 9, 2026.
An antifungal medicine used to treat serious fungal infections.
Products affected
2 / 12
In shortage since
Oct 31, 2025
Est. full return
Oct 9, 2026
Reports on file
37
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
VORICONAZOLE FOR INJECTION
200MG · POWDER FOR SOLUTION · JAMP PHARMA CORPORATION
DIN 02477696 · since Jun 30, 2026, est. end Oct 9, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP VORICONAZOLE
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02525771 · since Oct 31, 2025, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Resolved
VFEND
200MG · POWDER FOR SUSPENSION · PFIZER CANADA ULC
DIN 02279991 · ended Jun 26, 2026 · Disruption of the manufacture of the drug.
Resolved
VORICONAZOLE FOR INJECTION
200MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02381966 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
Resolved
VORICONAZOLE FOR INJECTION
200MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02381966 · ended Apr 13, 2026 · Disruption of the manufacture of the drug.
Resolved
VORICONAZOLE FOR INJECTION
200MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02493829 · ended Nov 14, 2025 · Fresenius Kabi Canada regrets to advise that due to release delays, we will be encountering a supply interruption.
Discontinued
TEVA-VORICONAZOLE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02396866
Discontinued
TEVA-VORICONAZOLE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02396874
Resolved
TEVA-VORICONAZOLE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02396866 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-VORICONAZOLE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02396874 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-VORICONAZOLE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02396866 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-VORICONAZOLE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02396874 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 37 reports. All reports are on file with Health Canada.
What's happening
Voriconazole is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Voriconazole is classified under “ANTIMYCOTICS FOR SYSTEMIC USE” (ATC J02AC).
Recent changes
Jul 10, 2026
Shortage resolved
Jul 10, 2026
Estimated end date moved earlier : Jun 29, 2026 → Jun 25, 2026
Common questions
What is Voriconazole used for?
An antifungal medicine used to treat serious fungal infections.
When will Voriconazole be back in stock in Canada?
The latest manufacturer estimate is Oct 9, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Voriconazole in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.